Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Put the claws away Newbie, everyone has their own interpretation of his expression…..but I say $hit eating grin…..yep, $hit eating grin for sure!
Giovanni’s reaction was about as telling as it gets,and more importantly, he had the perfect chance to quell the BO rumors and he didn’t.
And Purea, welcome to party pal, your BO revision is righteous buddy.
Phase 3 trials last between 1-4 years and only have about a 50% chance of FDA approval.
Gotta load up anytime we fall below 30!
There’s a lot of speculation on BO figures, the pessimists say 40-45, the realists say 50-60 and the optimist says over 60. In any event, all figures are well over the current price.
Booyay Dart!
Here here Jess
Thats the stuff!
Newbie, good job getting out and voting, it’s the American way!
I think “all the above would suffice “
I agree on Karma
This is hilarious, I’ve never heard this word. Before, but it’s in my vocabulary now!
So, JESS is a Fudster,
1) A neophyte who randomly posts doom and gloom about a stock that recently doubled and is about to again?
2) Is a Fudster a dude on an investor board who’s insensitive to Lupus patients because his wife says the insurance companies won’t foot the bill?
3) Is a Fudster a dude that should just step away from the keypad and let his wife do the posting, because he’s constantly quoting her?
Pick away Jess
Correct Zep, sounds like your playing tennis with a really naive poster today. I’ll bet it’s Biotech researcher under a different name, since he sold all of his position at $15.
For you LONGS, I’m sure most of you are familiar with wainwright. Ed Arce has been without a doubt the most accurate analyst following AUPH.
Yesterday, he gave a $40 PT and that’s without figuring a BO, he just raised this from $35. AUPH will easily hit $50 by 2Q next year going alone, there is no reason to accept anything under $60 for a 2021 BO.
Well stated ZZat
WHAL,you’re confused on most of everything your stating.The only thing I agree with is that yes, hell yes, we’re all hoping for a huge BO, that goes without saying.
You’re talking about small start up companies, we’re talking about AURINA PHARMACEUTICALS…..launching a brand new shiny drug only 9 months ago, with a very small sales force - all only with the company about a year-pitching this new drug when most hospitals are at peak capacity with Covid/delta patients, cancer, heart attacks, etc. With all of that going on AUPH rang in just under 15 million dollars, just in the past 3 months, more than doubling the prior quarter.This geometric progression in growth will continue especially against a far inferior Glasko drug, and as the smoke clears, sales numbers will become parabolic. I believe this is the bridge PG is negotiating with potential suitors.Don’t forget the IP for the drug, I believe it’s 2037….sound right Jess?
I agree buddy and for so many reasons, but the kicker for me is lack of denial on both parties on a BO.
Dart, your candor is both appreciated and refreshing on a board full of blowhards and exaggerations…ha!
Keep posting buddy!
Dart, you were in on IMMU also?.
I posted last week, AUPH is going exactly like IMMU did before it’s $88 BO.
Dart,great story man, and we’re only getting warmed up!
This article is spot on, I believe AUPH is in tough negotiations
Just under 15 million in sales in just three months with all the Covid/delta $hit going on and with a tiny sales force !!!???
The sky is the limit for VOC.
PG was the Michael Jordon of being cocky this morning, as if to say “offers are coming, but we’re not taking anything less than F’in stellar”
But not denying either
Peter declining to substantiate BO rumors
Wouldn’t surprise me Cosa
I expect good news Cosa
Buy before the earnings release tomorrow morning…
This will be the first earnings release before the bell AUPH has had as long as I can remember.I think PG is going to throw down some great news, then thrown down the mic.
You nailed it Jess, there is so much potential in those drugs!
Absolutely Cerv!
Ha, Glasko grabbing all of its toys and going home !
That’s the sweet spot Jess, I concur!
I love that!,
I owned IMMU last year, they were just like AUPH , a slightly bigger market cap. The price stuck around 20-30 for a few months, then some analysts raised their PT to 42., stood there for a few weeks then BAM GILEAD brought them out for 88 bucks a share.I see the exact same scenario with AUPH.
What’s your PT Jess?
I don’t know him Jess, who is he and what’s his BO price?
Most longs here paid that or less going in and have been adding accordingly, but thanks for telling us how much you paid, I feel sooooo much better now……searching my home to find a bozo button I can place on your proud chest!
I do agree with you on AVXL though, that’s gonna be a winner.
Amen Zzat, this is the final step in a major BO, alongside some really solid sales numbers Wednesday morning.I truly believe the BO won’t be below 58 and the BO will happen before 2022
Back at ya buddy
Can we close at 33 on a Friday!?
Meant weird part
Right!!??
Cerv, the word part is, Oppenheimer never even weighed in on AUPH until the stock hit 32, then they throw out a random 32 PT after BO rumors?
Wouldn’t surprise me if there was some internal shenanigans going on there.
Whal, my thoughts are any suitor looking to buy AUPH is privy to these results . ……although, the general public isn’t supposed to know for another month.
Good point Zep